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Incorporating scientific advancements into daily clinical practice 
is a logical and practical process by which to improve the qual-
ity of care provided to people with diabetes. Yet this potentially 
beneficial approach remains a largely unresolved issue in con-
temporary medicine. Significant progress has been made through 
translational research to bring research benefits ‘from bench to 
bedside’ or, more accurately in this case, ‘from lab to lifestyle’ to 
the benefit of people with diabetes and those at risk. However, as 
the author points out, challenges remain. In this article, Juan José 
Gagliardino describes a novel approach being taken by the Inter-
national Diabetes Federation via its BRIDGES programme to op-
timize and diffuse the public health benefits of the translational 
approach being applied in research projects underway worldwide.
Strong interest exists in partnerships 
between the community and academia 
as a means to improve population health 
through clinical research,1,2 and the issue 
has been addressed through transla-
tional research, which aims to bridge the 
gap between research and daily care.3 In 
order to facilitate this process, in 2006 
the US National Institutes of Health put 
forward the Clinical and Translational 
Science Award (CTSA) programme.4
At the same time, primary care Practice-
Based Research Networks (PBRN) – 
another strategy to close the gap be-
tween scientific achievements and their 
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local communities and national health 
authorities.7 BRIDGES has facilitated the 
construction of an international scientific 
network of experts in diabetes, and has 
been the catalyst behind a process to 
promote good-quality, evidence-based 
practices and procedures.
The wealth of experience gained during 
these recent years enabled us to recognize 
that although the traditional mechanisms 
of support for projects have been success-
ful, new strategies were required to en-
hance the power of translational research. 
With this in mind, IDF has begun test-
ing a new initiative, ‘BRIDGES Research 
Net’. It should be noted that BRIDGES 
application in daily-care practice – found 
that less, rather than more, translation 
is required to apply research to practice 
when clinicians are involved in deciding 
what to study, how to study it, and how 
to evaluate and present their results.
Translational challenges
The process of ‘marrying’ research with 
daily practice is not always a smooth 
one. It often requires a paradigmatic 
shift in terms of relationships, concep-
tual frameworks and even the languages 
used by different partners in order to 
communicate. The relationship between 
PBRN and the CTSA programme is in 
its ‘getting-to-know-you’ phase, and the 
participants are currently negotiating 
their expectations.5 It is possible, as has 
been suggested by a number of authors, 
that PBRN might evolve gradually from 
clinical laboratories into collaborative 
learning communities that use both tra-
ditional and non-traditional methods to 
identify, disseminate and integrate new 
knowledge in order to improve primary 
care processes and patient outcomes.6
In 2007, based on this collaborative 
principle, the International Diabetes 
Federation (IDF) and Lilly Diabetes 
agreed to take up an active role 
in translational research via IDF’s 
Building Research in Diabetes Global 
Environments and Systems (BRIDGES) 
programme. BRIDGES is managed inde-
pendently by IDF and supported finan-
cially by an educational grant of USD 10 
million provided by Lilly Diabetes. The 
overarching objectives of BRIDGES are 
to reduce the risk of developing type 2 
diabetes and its chronic complications; 
and ensure improved access to evidence-
based practice for people worldwide who 
have already developed the condition.
The results of BRIDGES activities – com-
pleted or still underway – across six con-
tinents have demonstrated the efficacy of 
community-based translational research 
projects in addressing 
the diabetes epidemic, 
as well as in strength-
ening partnerships 
within and between 
briDgeS aims to reduce 
the risk of developing 
type 2 diabetes and 
complications, and 
improve access to 
evidence-based 
practice for those 
affected worldwide.
new strategies 
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enhance the power of 
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Research Net uses unspent funds al-
located to the 4th round of BRIDGES 
funding. The aim of this initiative is 
to strengthen the sustainability of cur-
rent projects while replicating effective 
strategies in further locations – dissemi-
nating positive project outcomes and 
implementing successful interventions 
worldwide with (from the outset) the 
participation of local researchers and the 
direct involvement of local authorities.
A key condition of this initiative will 
be the involvement of local health au-
thorities, including health ministries, re-
searchers and IDF Member Associations, 
in order to devolve ownership of all 
activities and guarantee long-term self-
sustainability. Moreover, the participa-
tion of these key stakeholders will pro-
duce a quantum leap in awareness of 
diabetes; and significant improvements 
in primary and secondary prevention 
Blue circles indicate the sites of BRIDGES-supported research projects
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and treatment – and ultimately, opti-
mized quality both of the care provided 
to and of the lives of people with diabe-
tes and those at risk.
In order to select successful outcomes 
to date, BRIDGES Executive Committee 
and BRIDGES Review Committee will 
focus on the 38 projects (34 countries) 
that have already received grant fund-
ing, and are dedicated to primary and 
secondary prevention. The chosen in-
terventions (and methodologies) are 
then to be replicated in other locations 
around the world following a call for 
tender in the current year.
In an attempt to guarantee the success 
of this initiative, we will use the model 
developed for D-START, which involves 
the participation of international ex-
perts, the provision of training work-
shops, and continuous follow-up during 
the intervention phase. (Visit www.idf.
org/d-start for more on D-START.)
BRIDGES Research Net in action
BRIDGES Research Net will be tested 
on a project underway in Alexandria, 
Egypt, which is evaluating the impact 
of an educational preventive foot care 
centre for people with diabetes. With 
a reasonable financial investment and 
over a relatively short period, this pro-
ject achieved impressive results in dia-
betic foot management in Egypt:
■  Providing self-care education for 3,600 
people with diabetes and training for 
2,700 professionals
■  Reducing the prevalence of diabetes-
related nail infection from 65% to 27%
■  Reducing the prevalence of active 
diabetic foot ulcers from 11% to 3%
■  Initiating diabetes foot care teams in 
eight Egyptian universities.
A call for tenders is being drawn up based 
on this successful intervention. In or-
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Multi-party interaction 
will contribute to 
improvements in the 
quality of care provided 
to people with diabetes.
der to ensure future self-sustainability, 
the active role of local authorities will 
be stressed in the tender conditions and 
clearly outlined in the application process.
Selected applicants will join a three-
to-four-day onsite workshop, man-
aged by the Principal Investigator of 
the Egyptian project, ensuring that the 
quality of the original intervention is 
reproduced. Routine evaluations will 
take place during the period of imple-
mentation to make certain that the in-
tervention is running smoothly, that it 
is fully adapted to local needs, and that 
the pre-defined outcomes are measured 
and remain attainable.
It is our strong belief that BRIDGES 
Research Net will help to close the gap 
between basic and clinical research 
achievements and their incorporation 
into daily care practice, while strength-
ening relationships among local re-
searchers, health ministries, academic 
organizations and IDF. This multi-party 
interaction will contribute also to im-
provements in the quality of care pro-
vided to people with diabetes, and the 
incorporation of effective prevention 
strategies into daily practice at every 
level. These measures and the overall 
approach of the initiative will play a key 
role in preventing the development and 
progression of chronic complications. 
Such outcomes will help to reduce the 
burden of diabetes on society in general, 
and, above all, contribute to improved 
quality of life for people with diabetes.
For more information about this new ini-
tiative, please contact us at bridges@idf.org.
